Retrospective analysis of eliminating modified ultrafiltration after pediatric cardiopulmonary bypass

Craig M McRobb1, Richard J Ing2, D Scott Lawson1

  • 11 Department of Perfusion, Children's Hospital Colorado, Aurora, CO, USA.

Perfusion
|October 7, 2016
PubMed

Insights

Modified ultrafiltration (MUF) is a pediatric cardiac surgery technique. This study found that preventing hemodilution with miniaturized cardiopulmonary bypass (CPB) circuits is more advantageous than reversing it with MUF.

Area of Science:

  • Pediatric Cardiac Surgery
  • Cardiopulmonary Bypass Techniques
  • Hemodilution Management

Background:

  • Modified ultrafiltration (MUF) is a common post-cardiopulmonary bypass (CPB) procedure in pediatric open-heart surgery.
  • While MUF offers benefits, less-reported disadvantages exist, prompting a re-evaluation of its use.
  • Institutional practice shifted away from MUF, prioritizing simplified and miniaturized CPB circuits.

Purpose of the Study:

  • To compare outcomes before and after discontinuing MUF in pediatric patients undergoing open-heart surgery.
  • To evaluate the impact of a miniaturized CPB circuit on hemodilution and transfusion requirements.
  • To assess the safety and efficacy of preventing hemodilution versus reversing it with MUF.

Main Methods:

  • Retrospective analysis of 160 pediatric patients (<8kg) over 38 months.
  • Patients divided into neonatal and pediatric cohorts.
  • Key parameters analyzed: demographics, hematocrit, blood product transfusion, hemostasis, hemodynamics, and outcomes.

Main Results:

  • The study compared data before and after the discontinuation of MUF.
  • Analysis focused on the benefits of preventing hemodilution through circuit miniaturization.
  • Findings support the advantage of preventing hemodilution over reversing it with MUF in the studied population.

Conclusions:

  • Preventing hemodilution via miniaturized CPB circuits demonstrates advantages over reversing hemodilution with MUF.
  • This approach may reduce transfusion needs and improve safety in pediatric cardiac surgery.
  • The findings support a practice change towards optimized CPB circuit design.

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
315
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.6K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
756